Clinical Trial Update: COVID-19 Vaccine Boosters in Patients With CKD [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating COVID-19 vaccine boosters in patients with chronic kidney disease was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• COVID-19 vaccine booster

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Chronic Kidney Diseases, COVID-19 | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2025-02-19